![Mieke van Acker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Mieke van Acker first degree
Entity | Entity type | Industry | |
---|---|---|---|
MyCartis NV
![]() MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mieke van Acker via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Pacira CryoTech, Inc.
![]() Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
NeoSync, Inc.
![]() NeoSync, Inc. Medical SpecialtiesHealth Technology NeoSync, Inc. is a clinical-stage firm. It develops non-invasive neuromodulation products to treat major depressive disorder and other diseases of the central nervous system. The firm's technology, NeoSync-EEG Synchronized TMS, is personalized to a patient’s individual alpha frequency. The company was founded by Bill Phillips and is headquartered in South Boston, MA. | Medical Specialties | Director/Board Member | |
4Tech Cardio Ireland Ltd.
![]() 4Tech Cardio Ireland Ltd. Medical SpecialtiesHealth Technology 4Tech Cardio Ireland Ltd. develops and manufactures surgical devices. The company was founded in 2011 and is headquartered in Waltham, MA. | Medical Specialties | Director/Board Member | |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Founder | |
Biovest CVA | Chief Executive Officer | ||
Korys Management NV
![]() Korys Management NV Investment ManagersFinance Korys Management NV is a Private Equity/Venture Capital firm, a subsidiary of Korys NV founded in 2000. Korys Management NV is headquartered in Halle. | Investment Managers | Private Equity Analyst | |
Participatiemaatschappij Vlaanderen NV
![]() Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor | |
deVGen NV
![]() deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director of Finance/CFO | |
ABLYNX | Biotechnology | Director/Board Member | |
Ghent University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
Institut d’Administration des Entreprises | College/University | Graduate Degree | |
FORMAC Pharmaceuticals NV
![]() FORMAC Pharmaceuticals NV Pharmaceuticals: GenericHealth Technology FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium. | Pharmaceuticals: Generic | Director/Board Member | |
reMYND NV
![]() reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
CELYAD ONCOLOGY SA | Biotechnology | Chairman Director/Board Member | |
Vesalius Biocapital I SA SICAR
![]() Vesalius Biocapital I SA SICAR Investment ManagersFinance Vesalius Biocapital I SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. | Investment Managers | Director/Board Member | |
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
FlandersBio vzw
![]() FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Gengest BV | Chief Executive Officer | ||
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Amakem NV
![]() Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Director/Board Member | |
LMA BV | Chief Executive Officer | ||
Université d'Aix-Marseille | College/University | Graduate Degree | |
Mérieux Equity Partners SAS
![]() Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country. | Investment Managers | Consultant / Advisor | |
JenaValve Technology, Inc.
![]() JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member Director/Board Member | |
Valiance Advisors LLP
![]() Valiance Advisors LLP Investment ManagersFinance Valiance Advisors LLP is the alternative asset management subsidiary of Valiance Asset Management Ltd. in Great Britain. The firm was founded by Jan Pensaert in 2008. Headquartered in London, Valiance Advisors manages Life Sciences portfolio for individual and institutional investors. | Investment Managers | Chief Executive Officer | |
University of Antwerp | College/University | Doctorate Degree | |
Valiance Asset Management Ltd.
![]() Valiance Asset Management Ltd. Financial ConglomeratesFinance Valiance Asset Management Ltd. provides investment services. It offers sovereign funds, pension funds, leading families and individuals investment services. The company was founded by Jan Pensaert in 2008 and is headquartered in St. Peter Port, Guernsey. | Financial Conglomerates | Chief Executive Officer | |
Vesalius Biocapital II SA SICAR
![]() Vesalius Biocapital II SA SICAR Investment ManagersFinance Vesalius Biocapital II SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. | Investment Managers | Director/Board Member | |
Magenta Medical Ltd.
![]() Magenta Medical Ltd. Medical SpecialtiesHealth Technology Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel. | Medical Specialties | Director/Board Member | |
BIOTALYS NV | Chemicals: Agricultural | Director/Board Member Director/Board Member | |
Mimetas BV
![]() Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
eSATURNUS NV
![]() eSATURNUS NV BiotechnologyHealth Technology eSATURNUS NV provides healthcare services for hospitals, doctors, nursing staff, and patients. The company was founded by Thomas Koninckx and Bob Koninckx on April 6, 2007 and is headquartered in Leuven, Belgium. | Biotechnology | Director/Board Member | |
BIOCARTIS GROUP NV | Medical Specialties | Chairman Chief Executive Officer | |
Confo Therapeutics NV
![]() Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
BlueBee Holding BV
![]() BlueBee Holding BV Medical SpecialtiesHealth Technology Bluebee Holding BV engages in the development of a private cloud-based accelerated genomics platform. It supports cross-functional teams of life science researchers and clinicians by effectively centralizing and managing their genomics data processes and storage needs. The company was founded in 2011 by Vlad-Mihai Sima, Koen Bertls, Luk Wayne, and Zaid Al-Ars and is headquartered in Rijswijk, the Netherlands. | Medical Specialties | Director/Board Member | |
Summa Equity AB
![]() Summa Equity AB Investment ManagersFinance Summa Equity AB (Summa Equity) is a private equity firm founded in 2016 by Jenny Keisu, Reynir Kjær Indahl and Johannes Hidle Lien. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
Valiance Life Science Investments
![]() Valiance Life Science Investments Investment ManagersFinance Valiance Life Science Investments (Valiance Life Science Investments) is a private equity subsidiary of Valiance Asset Management Ltd. founded in 2017. The firm headquartered in London, United Kingdom. | Investment Managers | Founder | |
High Command Productions Ltd.
![]() High Command Productions Ltd. Movies/EntertainmentConsumer Services Part of Paramount Global, High Command Productions Ltd. is a British company that engages in motion picture and video production. The company is based in London, UK and was founded in 1978. | Movies/Entertainment | Director/Board Member | |
Antelope Dx BV
![]() Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Packaged Software | Director/Board Member Founder | |
Keep Life Stories, Inc.
![]() Keep Life Stories, Inc. Packaged SoftwareTechnology Services Keep Life Stories, Inc. develops an audio-based application. It automatically captures and save life story of a loved one on audio. The company was founded by Amelia Lin and is headquartered in Mountain View, CA. | Packaged Software | Director/Board Member | |
Microbial Resource Management Technologies NV
![]() Microbial Resource Management Technologies NV Miscellaneous Commercial ServicesCommercial Services Microbial Resource Management Technologies NV provides business management consulting services. The private company is based in Ghent, Belgium. The Belgian company was founded in 2016 by Sam Possemiers, Willy Verstraete, Massimo Marzorati. | Miscellaneous Commercial Services | Director/Board Member | |
Oncode BV
![]() Oncode BV Investment ManagersFinance Oncode BV is a venture capital firm, a subsidiary of Oncode Institute, founded in 2018. Oncode BV is headquartered in Utrecht. | Investment Managers | Corporate Officer/Principal | |
Laboraco BV | Chief Executive Officer | ||
Sengenics Corp Pte Ltd
![]() Sengenics Corp Pte Ltd Miscellaneous Commercial ServicesCommercial Services Sengenics International Pte Ltd. develops arrays used in genomics research. It is a genomics and proteomics-based research and diagnostics company with a range of patented technologies and products that are marketed to pharmaceutical companies, scientists and hospitals. The firm flagship technology is the patented Immunome auto-antibody profiling platform which was spun out from research that was commercialized as a joint collaboration between the University of Oxford and the University of Cambridge. The company is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
IQVIA MedTech NV
![]() IQVIA MedTech NV BiotechnologyHealth Technology IQVIA MedTech NV develops and commercializes investigational products and therapies. Its services include project and site management, monitoring, auditing, and risk-based monitoring. The company was founded by Bert Segers and Aly Talen in 2005 and is headquartered in Antwerp, Belgium. | Biotechnology | Director/Board Member |
Statistics
International
Belgium | 28 |
United States | 6 |
United Kingdom | 6 |
France | 4 |
Netherlands | 4 |
Sectoral
Health Technology | 20 |
Finance | 12 |
Consumer Services | 7 |
Commercial Services | 6 |
Health Services | 3 |
Operational
Director/Board Member | 65 |
Chief Executive Officer | 16 |
Independent Dir/Board Member | 8 |
Founder | 8 |
Corporate Officer/Principal | 7 |
Most connected contacts
Insiders | |
---|---|
Rudi Mariën | 31 |
Hilde Windels | 18 |
Christoph Waer | 16 |
Chris de Jonghe | 15 |
Jan Pensaert | 13 |
Wouter Laroy | 2 |
- Stock Market
- Insiders
- Mieke van Acker
- Company connections